Compliance problems in the treatment of schizophrenic patients;Compliance-probleme bei der behandlung schizophrener patienten

Wiener Medizinische Wochenschrift

Volumn 148, Issue 11-12, 1998, Pages 281-283

  Barnas, C ^a   Hummer, Martina ^b   Fleischhacker, W W ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Univ Klinik für Psychiatrie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BEHAVIOR; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN; SCHIZOPHRENIA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; SCHIZOPHRENIA;

EID: 0031902049     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Becker MH, Maimann LA: Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975;13:10-24.
2. Di Matteo MR, Di Nicola DD: Achieving patient compliance, New York. Pergamon Press, 1982.
3. Geller JL: State hospital patients and their medication - do they know what they take? Am J Psychiat 1982;139:611-615.
4. Haynes RB in Haynes RB, Taylor TW, Sackett DL (eds): Compliance Handbuch. München-Wien. Oldenburg, 1982.
5. Hoffmann H: Age and other factors relevant to the rehospitalization of schizophrenic outpatients. Acta Psychiat Scand 1994;89:205-210.
6. Hoge SK, Appelbaum PS, Lawlor T: A prospective, multicenter study of patients' refusal of antipsychotic medication. Arch Gen Psychiat 1990;47:949-956.
7. Kane JM: Compliance issues in outpatient treatment. J Clin Psychopharmacol 1985;5 (suppl 3): 22.
8. Kane JM: Treatment of schizophrenia. Schizophrenia Bull 1987; 13:33-56.
9. Kissling W: Consensus regarding indication for prophylactic treatment - necessary but unattainable? In Barnes TRE (eds): Depot neuroleptics - a consensus, London. Mediscript. 1988, pp 41-46.
10. Kissling W, Fleischhacker WW: Optimising prophylactic treatment of schizophrenia by means of treatment standards and compliance improvement. Pharmacopsychiatry 1992;25:69-71
11. Ley P. Spelman MS: Communication in an outpatient setting. Br J Soc Clin Psychol 1965;4:114-116.
12. Linden M: Therapeutische Ansätze zur Verbesserung von Compliance. Nervenarzt 1979;50:109-114.
13. Linden M: Negative vs positive Therapieerwartungen und Compliance vs Non-Compliance. Psychiat Prax 1987;14:132-136.
14. Ludwig W, Huber D, Schmidt S, Bender W, Greil W: Assessment of compliance related attitudes in psychiatry. Soc Psychiaty Psychiatr Epidemiol 1990;25:298-303.
15. Maurer K, Biehl H: Klinikaufenthalte und produktive Rückfälle bei ersterkrankten Schizophrenen. Determinanten des Zeitverlaufs zwischen stationären Aufnahmen bzw. Schizophrenen Rückfällen über fünf Jahre. Nervenheilkunde 1988;7:279-290.
16. McEvoy JP, Apperson LJ, Appelbaum PS: Insight in schizophrenia. First relationship to acute psychopathology. J Nerv Ment Dis 1989;177:43-47.
17. Pfeiffer W, Kockott G, Fischl B, Schleuneng G: Unerwünschte Wirkungen psychopharmakologischer Langzeittherapie auf die sexuellen Funktionen. Psychiatr Prax 1991;18:92-98.
18. Schwartz D, Wang M, Zeitz L, Gross ME: Medication errors made by elderly, chronically ill patients. Am J Public Health 1962;52:2018-2029.
19. Silverstone T, Smith G, Goodall E: Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiat 1988;153:214-217.
20. Willcox DRC, Gillan R, Hare EH: Do psychiatric outpatients take their drugs? Br Med J 1965;2:790-792.
21. Young IL, Zonana HV, Shepler L: Medication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiat Law 1986;14:105-122.